Yüklüyor......
Phthalides serve as potent modulators to boost fetal hemoglobin induction therapy for β-hemoglobinopathies
Fetal hemoglobin (HbF) induction therapy has become the most promising strategy for treating β-hemoglobinopathies, including sickle-cell diseases and β-thalassemia. However, subtle but critical structural difference exists between HbF and normal adult hemoglobin (HbA), which inevitably leads to redu...
Kaydedildi:
| Yayımlandı: | Blood Adv |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
American Society of Hematology
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6517670/ https://ncbi.nlm.nih.gov/pubmed/31072835 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2019031120 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|